Their results showed that IMCL could serve as an additional parameter/biomarker for increased diabetes risk, since it identifies insulin resistance in pGDM patients and also those patients who were diagnosed previously and/or required insulin throughout pregnancy [33]. The gene discussed is INS; the disease is diabetes mellitus.